Tyvaso inhaled treprostinil regulatory update

United Therapeutics withdrew an MAA for inhaled Tyvaso treprostinil to treat pulmonary arterial hypertension (PAH) after the European Medicines Agency's CHMP issued a major objection to the applicatio...